HSS Annual Report 2018-19
Annual Report slider
What Moves Us Forward Moves Us All
HSS is an organization in perpetual motion. As global leaders in orthopaedics and rheumatology, it is our imperative to constantly innovate, both in the care we provide and in the basic, translational and clinical research that forms the bedrock of that care.
Discover how HSS experts advanced complex care in the fields of adult orthopaedics, pediatric orthopaedics and rheumatology in 2018-19. (Read our most recent annual report.)
Annual Report Highlights from Adult Orthopaedics
Browse news and video highlights below.
The Science of Disc Degeneration
Why is it that some degenerative discs cause such pain? Orthopaedic surgeon Todd Albert, MD, and scientist Chitra Dahia, PhD, have gone into the lab to address fundamental questions about back pain and its causes.
The Future of Custom Implants, in Three Dimensions
For patients with complex joint replacement needs, 3D customized implants offer an effective solution for cases that would otherwise be nearly untreatable.
The Evolving Role of MRI in Joint Arthroplasty
Doctors in the Department of Radiology and Imaging at HSS are pioneering the use of a technique once thought impossible, maybe even unsafe: examining metal joint replacements in the body using MRI.
Laying a Foundation of Evidence for Regenerative Medicine
The field of regenerative medicine is rapidly evolving. In the new Center for Regenerative Medicine at HSS, clinicians are studying these cutting-edge therapies and overseeing their use in patients.
How HSS Is Changing Its Opioid Prescription Practices
In 2017, HSS launched a Controlled Substances Task Force — a major part of a comprehensive effort to promote culture change around opioid prescribing — and implemented guidelines around opioid use. Since that time, HSS clinicians have prescribed approximately 1 million fewer opioid pills, standardized how high-risk patients are identified and also augmented provider and patient education.
Overcoming Challenges in Total Ankle Replacement
HSS orthopedic surgeons and biomechanical engineers are teaming up to enhance the design of ankle prostheses. The research draws upon data generated by a robotic gait simulator. Orthopedic surgeon Constantine Demetracopoulos, MD, explains how the work could lead to longer-lasting ankle implants for patients.
- The State of the World of Musculoskeletal Health (2017-2018)
- The State of the World of Musculoskeletal Health (2016-2017)
- Dedication. Precision. Impact. (2015-2016)
- The Outsized Impact of Orthopaedics (2014-2015)
- Game Changers (2013-2014)
- A Return to Form and Function: The Essential Work of HSS (2012-2013)
- Around the World in Many Ways (2011-2012)
Annual Report Highlights from Pediatric Orthopaedics
Browse news and video highlights below.
Risk Stratification for Patients Under 20 with ACL Injuries
What is the optimal way to treat ACL tears in patients under 20? Pediatric orthopaedic surgeon Daniel Green, MD, explains how a new multicenter study may hold the key to keeping young athletes on the field.
Revolutionizing Spinal Imaging — without Radiation
In 2019, HSS embarked on implementing a novel method of spinal imaging that does not require ionizing x-ray radiation — particularly important for pediatric patients.
Getting a Better View during Complicated Foot and Ankle Surgeries
Pediatric orthopaedic surgeons at HSS have incorporated a variety of technologies into foot and ankle procedures over the last several years to improve accuracy — and potentially results.
Collecting Patient-Reported Outcomes as Standard of Care for Pediatric Patients
Collecting information on how patients feel after surgery is vital to improving outcomes. The practice is now standard procedure for pediatric patients at HSS.
Annual Report Highlights from Rheumatology
Browse news and video highlights below.
Growing Awareness of Chronic Recurrent Multifocal Osteomyelitis
Chronic recurrent multifocal osteomyelitis is a rare autoinflammatory bone disorder that is often misdiagnosed in children and adults. Pediatric rheumatologist Karen Onel, MD, describes the efforts she's leading to build a profile of the disease.
Charting a Course for Personalized Rheumatoid Arthritis Treatment
Scientists at HSS are using cutting-edge laboratory techniques to make sense of RA at a cellular level, with the hope of cultivating more targeted treatments.
New Registry Tracks a Surprising Rheumatologic Side Effect of Cancer Treatment
Immunotherapy drugs called checkpoint inhibitors have been a game changer for people with certain cancers—but they are also causing a surprising new form of arthritis.
A New Outlook on Pregnancy in Women with Lupus
Advances in diagnosis and treatment have dramatically improved outcomes for people with rheumatic disease, including women wishing to become pregnant.
The Latest Scleroderma Treatment Strategies
Doctors know how to treat the complications of scleroderma, but what about the underlying disease? A possible new strategy being studied in a clinical trial takes aim at B cells.